Sandhill Capital Partners’s Idexx Laboratories IDXX Stock Holding History
Bought
Maintained
Sold
Other funds holding IDXX
Sandhill Capital Partners's IDXX Position: Q2 2019 in Review
Sandhill Capital Partners sold out of Idexx Laboratories (IDXX) in Q2 2019, closing a stake of 54,528 shares — an estimated $12.2M sold.
Sandhill Capital Partners first reported a position in IDXX in Q4 2015 and held it in 14 quarters. The position peaked at $17.7M in Q1 2018. 715 funds tracked by Wall St. Rank hold IDXX as of Q2 2019.
- Sandhill Capital Partners reported no remaining Idexx Laboratories position as of Q2 2019 after selling out during the quarter.
- Sandhill Capital Partners sold 54,528 Idexx Laboratories shares in Q2 2019, an estimated $12.2M.
- Sandhill Capital Partners first reported a position in Idexx Laboratories in Q4 2015 and held it in 14 quarters.
- Sandhill Capital Partners's Idexx Laboratories position peaked at $17.7M in Q1 2018.
- 715 funds tracked by Wall St. Rank held Idexx Laboratories as of Q2 2019.
Based on Sandhill Capital Partners's 13F filing for Q2 2019, filed 13 Aug 2019.